The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer

Aktuelle Urologie

Volumn 34, Issue 4, 2003, Pages 247-249

  Matsuyama, H ^a   Pan, Y ^b   Oba, K ^a   Yoshihiro, S ^a   Matsuda, K ^a   Hagarth L ^b   Kudren, D ^b   Naito, Katsusuke ^a,b   Bergerheim, U S R ^b,c   Ekman, P ^b  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

Author keywords

Disease progression; FISH; Prostate cancer

Indexed keywords

ADULT; AGED; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CHROMOSOME 8P; CHROMOSOME DELETION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENETIC MARKER; HUMAN; HUMAN TISSUE; JAPAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; SWEDEN; TISSUE SECTION; TREATMENT OUTCOME; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 0042333265     PISSN: 00017868     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41607     Document Type: Conference Paper

References (9)

1. Chev M, Lewis P, Banerjee M, Hurley P, Sakr W, Grignon D, Powell I. A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian-Americans. Clin Cancer Res 1988; 4: 1273-1278
2. Trapasso J, deKernion J, Smith R, Dorey F. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 1994; 152: 1821-1825
3. Sato K, Qian J, Slezak JM, Lieber MM, Bostwick DG, Bergstrahl EJ, Jenkins RB. Clinical significance of alterations of chromosome 8 in highgrade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst 1999; 91: 1574-1580
4. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim US. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 1994; 9: 3071-3076
5. Pan Y, Matsuyama H, Wang N, Yoshihiro S, Haggarth L, Li C, Tribukait B, Ekman P, Bergerheim U. Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer. Prostate 1998; 36: 31-38
6. Schellhammer P, el-Mahdi A, Kuban D, Wright GJ. Prostate-specific antigen after radiation therapy. Prognosis by pretreatment level and post-treatment nadir. Urol Clin North Am 1997; 24: 407-414
7. Matsuyama H, Bergerheim USR, Nilsson I, Pan Y, Skoog L, Tribukait B, Ekman P. Non-random numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 1994; 77: 118-124
8. Oba K, Matsuyama H, Yoshihiro S, Kishi F, Takahashi M, Tsukamoto M, Kinjo M, Sagiyama K, Naito K. Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer. Cancer Genet Cytogenet 2001; 124: 20-26
9. Cabeza AY, Sepulveda JL, Lebovitz RM, Thompson TC, Chinault AC. Functional identification of LZTS 1 as a candidate prostate tumor suppressor gene on human chromosome 8p22. Oncogene 2001; 20: 4169-4179